Medicine and Dentistry
Accuracy
22%
Amphiregulin
13%
Analysis
36%
Assessment
13%
Bevacizumab
13%
Breast Cancer
13%
Bupivacaine
13%
Carboplatin
27%
Cells
40%
Combination Therapy
41%
Computer Assisted Tomography
13%
Consultation
13%
Cytoreductive Surgery
16%
Development
15%
Disease
21%
down Regulation
18%
Endometrial Cancer
67%
Endometrium Carcinoma
24%
Epithelium
27%
Gene
26%
Gestational Trophoblastic Disease
13%
Glycosaminoglycan
13%
Gynecological Oncology
27%
Health
13%
Histology
15%
Hysterectomy
18%
Immunohistochemistry
17%
Inpatient
19%
Krukenberg Tumor
28%
Laparotomy
13%
Malignant Neoplasm
40%
Mitochondrion
13%
Neoplasm
50%
Ovarian Cancer
54%
Paclitaxel
28%
Pathologist
13%
Pathology
13%
Patient
100%
Personalized Medicine
13%
Placebo
13%
Protein
13%
Randomized Controlled Trial
13%
Recurrent Disease
13%
Risk Stratification
18%
Small Intestine Obstruction
13%
Stromal Cell
27%
Surgery
17%
Therapeutic Procedure
69%
Uterine Myomectomy
13%
Woman
23%
Biochemistry, Genetics and Molecular Biology
Age
5%
Amphiregulin
13%
Apoptosis
6%
Ataxia Telangiectasia and Rad3 Related
13%
Autocrine Signalling
13%
Cancer Cell
33%
Carcinogenesis
7%
Cell Cycle Arrest
5%
Classification
11%
Deubiquitinating Enzyme
13%
Development
11%
DNA Mismatch Repair
13%
down Regulation
9%
Drug Resistance
11%
Evolution
13%
Genetic Marker
6%
Glycosaminoglycan
9%
Growth Factor
9%
Heparan Sulfate
13%
Heparin
9%
MDA-MB-468
9%
Microsatellite DNA
22%
Microsatellite Instability
12%
Mitochondrial Respiration
9%
Mitochondrion
13%
Mole (Insectivora)
13%
Mortality
7%
Mutation
27%
Nested Gene
10%
P53
6%
Polymerase
13%
RNA
9%
Solid
9%
Spectrum
9%
Subtyping
6%
Transcriptome
8%
USP14
13%
Pharmacology, Toxicology and Pharmaceutical Science
Bevacizumab
13%
Biological Marker
15%
Bupivacaine
13%
Cell Cycle
5%
Chemotherapy
15%
Cytotoxicity
13%
Deubiquitinase
9%
Diseases
12%
DNA Topoisomerase
13%
Endometrium Cancer
13%
Firtecan
13%
Fluorouracil
13%
Folinic Acid
13%
Ganitumab
13%
Malignant Neoplasm
19%
Molecular Target
13%
Ovary Cancer
34%
Paclitaxel
9%
Pixatimod
13%
Poisons
13%
Recurrent Disease
13%
Thymidine Triphosphate
13%
Trophoblastic Tumor
13%
Vasculotropin
13%
Vasculotropin A
6%